Freshly Funded ImCheck Goes After Gamma Delta T-Cells

$53m Series B Financing Will Advance ImCheck Therapeutics’ Pipeline

Immune_System
Gamma delta T-cells have active role in body's early immune response • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Immuno-oncology

More from Anticancer